QI
PACB icon

QS Investors’s Pacific Biosciences PACB Stock Holding History

QS Investors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$934K Hold
26,700
– – 0.01% 515
2021
Q1 		$890K Buy
26,700
+2,100
+9% +$73.5K 0.01% 570
2020
Q4 		$638K Buy
+24,600
New +$418K 0.01% 668
2016
Q4 		– Sell
-51
Closed -$1K – 1950
2016
Q3 		$1K Buy
51
+15
+42% +$125 ﹤0.01% 1686
2016
Q2 		$1K Buy
+36
New +$329 ﹤0.01% 1732
2016
Q1 		– Sell
-36,521
Closed -$480K – 2041
2015
Q4 		$480K Buy
+36,521
New +$328K ﹤0.01% 904
2015
Q2 		– Sell
-2,707
Closed -$16K – 1453
2015
Q1 		$16K Hold
2,707
– – ﹤0.01% 1338
2014
Q4 		$22K Buy
+2,707
New +$17.3K ﹤0.01% 1235

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Investors's PACB Position: Q2 2021 in Review

QS Investors held its Pacific Biosciences (PACB) position steady in Q2 2021 at 26,700 shares worth $934K. The position accounts for 0.01% of the portfolio, ranked #515.

QS Investors first reported a position in PACB in Q4 2014 and has held it in 8 quarters since. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

  • QS Investors held 26,700 shares of Pacific Biosciences worth $934K as of Q2 2021.
  • QS Investors left its Pacific Biosciences share count unchanged in Q2 2021.
  • Pacific Biosciences made up 0.01% of QS Investors's portfolio in Q2 2021, its #515 holding.
  • QS Investors first reported a position in Pacific Biosciences in Q4 2014 and has held it in 8 quarters since.
  • 262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.